K. Ryan

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis

H. Wishart, C. Fadul, R. Noelle, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Cryptogenic Epilepsy: An Infectious Etiology?

T. Tosteson, J. Schwartzman, V. Thadani, 2001, Epilepsia.

A phase I trial of an interleukin‐12/23 monoclonal antibody in relapsing multiple sclerosis

T. Vollmer, M. Mascelli, D. Everitt, 2006, Current medical research and opinion.

Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy

Jeffrey A. Cohen, S. Cole, D. Arnold, 2002, Multiple sclerosis.

Working memory in multiple sclerosis: Relation of fMRI activation to lesion volume

James C. Ford, A. Saykin, H. Wishart, 2001, NeuroImage.

Brain activation patterns associated with working memory in relapsing-remitting MS

A. Saykin, B. McDonald, H. Wishart, 2004, Neurology.

FLAIR lesion volume in multiple sclerosis: Relation to processing speed and verbal memory

A. Saykin, H. Wishart, A. Mamourian, 2005, Journal of the International Neuropsychological Society.